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Background. Nebraska (NE) Infection Control Assessment and Promotion 
Program (ICAP) is a quality improvement initiative supported by the NE Department of 
Health and Human Services. This initiative utilizes subject matter experts (SMEs) includ-
ing infectious diseases physicians and certified infection preventionists (IP) to assess and 
improve infection prevention and control programs (IPCP) in various healthcare set-
tings. NE ICAP conducted on-site surveys and observations of IPCP in many volunteer 
facilities to include long-term care facilities (LTCF) between November 2015 and July 
2017. SMEs provided on-site coaching and made best practice recommendations (BPR) 
for priority implementation. Impact of this intervention on LTCF IPCP was examined.
Methods. Using a standardized questionnaire, follow-up phone calls were 
made with LTCF to evaluate implementation of the BPR one-year post-assessment. 
Descriptive analyses were performed to examine BPR implementation in LTCF that 
had follow-up between 4/4/17 to 4/17/18 and to identify factors that promoted or 
impeded BPR implementation.
Results. Overall, 45 LTCF were assessed. The top 5 IC categories requiring 
improvement were audit and feedback practices (28 of 45, 62%), PPE supplies at point 
of use (62%), IC risk assessments (58%), TB risk assessments (56%), and supply and 
linen storage practices (56%). Follow-up assessments were completed for 270 recom-
mendations in 25 LTCF. Recommendations reviewed ranged from three to 26 per 
LTCF (median = 15). The majority of the 270 recommendations (n = 162, 60%) had 
been either completely (35%) or partially (25%) implemented by the time of the fol-
low-up calls. The ICAP visit itself was reported as the most helpful resource for BPR 
implementation (77 of 162). Lack of staffing was the most commonly mentioned bar-
rier to implementation when LTCF implemented BPR partially or implementation was 
not planned (37 of 85). BPR Implementation most frequently involved additional staff 
training (64 of 162), review of policies and procedures (38 of 162), and implementing 
audit (34 of 162) and/or feedback (23 of 162) programs.
Conclusion. Numerous IC gaps exist in LTCF. Peer-to-peer feedback and coach-
ing by SMEs facilitated implementation of many BPR directed toward mitigating iden-
tified IC gaps.
Disclosures. All authors: No reported disclosures.
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Background. Outpatient prescribing for acute uncomplicated cystitis is a sig-
nificant driver of antimicrobial use. Empiric therapy should be based on local sus-
ceptibility data. However, there is limited guidance on regional susceptibility trends 
in outpatient settings. This study describes the epidemiology and prevalence of anti-
microbial resistance in uropathogens in New York State outpatient settings to help 
inform empiric treatment decisions.
Methods. Retrospective analysis of positive urine cultures sent to Quest 
Diagnostics in 2016 from outpatient settings. Cultures that grew ≥105 CFU/mL were 
included from 17 NYS counties. Bacterial identification and antimicrobial sensitivities 
were determined on the Vitek-2 using CLSI M-100 S-25 breakpoints. Data were sum-
marized as proportions and stratified by age (<17, 18–64, ≥65) and sex.
Results. Over 78,000 isolates were included (Table 1). The most prevalent isolates 
were Escherichia coli (65.2%), Enterococcus spp. (11.9%), and Klebsiella pneumoniae 
(9.9%). E.  coli was highly susceptible to nitrofurantoin (NTF, 97.2%) and cefazolin 
(CFZ, 89.9%) and less susceptible to trimethoprim–sulfamethoxazole (TMP-SMX, 
72.9%) and ciprofloxacin (CIP, 78.0%). Enterococcus spp. was highly susceptible to 
NTF (99.0%) and ampicillin (99.8%). K. pneumoniae was highly susceptible to TMP-
SMX (90.0%) and CIP (95.2%) and markedly less susceptible to NTF (42.0%). E. coli 
was more prevalent in females (69.7% vs. 39.6%, P < 0.001). Enterococcus was more 
prevalent in males (39.6% vs. 10.1%, P < 0.001). The prevalence of K. pneumoniae was 
similar in men and women (9.6% vs. 10.1%, P = 0.08). Resistance was more prevalent 
in males (NTF: 6.3% vs. 4.2%; TMP-SMX: 26.3% vs. 22.7%; CIP: 35% vs. 17.3%) and 
for adults ≥65 (NTF: 6.2% vs. 3.6%; TMP-SMX: 25.1% vs. 22.1%; CIP: 30.0% vs. 14.0%) 
P < 0.001 for all comparisons.
Conclusion. NTF appears to be the best empiric choice for outpatient treatment 
of acute uncomplicated cystitis in New York State. TMP-SMX and ciprofloxacin should 
be avoided empirically. These data also highlight the necessity to obtain uropathogen 
sensitivity data to confirm empiric therapy or make appropriate adjustments in the 
outpatient setting.
Table 1. Summary of Antimicrobial Susceptibilities
Disclosures. T. P. Lodise Jr., Motif BioSciences: Board Member, Consulting fee.
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Background. Long-term care facilities (LTCFs) face several barriers to creating 
antibiograms. Here, we evaluate if LTCFs can use antibiograms from affiliated hospitals 
as their own antibiogram.
Methods. Facility-specific antibiograms were created for all Veterans Affairs (VA) 
LTCFs and VA Medical Centers (VAMCs) for 2017. LTCFs and affiliated VAMCs were 
paired and classified as being on the same campus or geographically distinct campuses based 
on self-report. For each pair, Escherichia coli susceptibility rates (%S) to cefazolin, ceftriax-
one, cefepime, ciprofloxacin, nitrofurantoin, sulfamethoxazole/trimethoprim, ampicillin/
sulbactam, piperacillin/tazobactam, and imipenem were compared. As guidelines discour-
age empiric use of antibiotics if susceptibility rates are <80%, we assessed clinical discordance 
between each LTCF and affiliated VAMC antibiogram at a threshold of 80% susceptible. The 
proportions of concordant susceptibilities between LTCFs and VAMCs on the same campus 
vs. geographically distinct campuses were compared using Chi-square tests.
Results. A total of 119 LTCFs and their affiliated VAMCs were included in this 
analysis, with 70.6% (n = 84) of facilities located on the same campus and 29.4% (n 
= 35) on geographically distinct campuses. The table below shows the overall clinical 
concordance (agreement) of LTCFs with their affiliated VAMC in regards to E. coli %S 
to the compared antibiotics. No significant differences were found when comparing 
LTCFs on the same campus vs. geographically distinct campuses.
Agreement Rates between LTCFs  
and Affiliated VAMCs Antibiotics
90–100% Ampicillin/sulbactam
Imipenem
Nitrofurantoin
80–89% Cefepime
Ciprofloxacin
Piperacillin/tazobactam
70–79% Sulfamethoxazole/trimethoprim
60–69% Cefazolin
Ceftriaxone
Conclusion. Antibiograms between LTCFs and affiliated VAMCs had a high 
concordance, except for sulfamethoxazole/trimethoprim, cefazolin and ceftriaxone in 
regards to susceptibility rates of E. coli. Facilities on the same campus were found to 
have similar concordance rates to geographically distinct facilities. Future studies are 
needed to investigate how the various approaches to creating LTCF-specific antibio-
grams are associated with clinical outcomes.
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Background. Little is known about infection control (IC) practice gaps in outpa-
tient hemodialysis centers (OHDC). Hence, we examined the frequency of IC gaps and 
the factors associated with them.
Methods. The Nebraska (NE) Infection Control Assessment and Promotion 
Program (ICAP) in collaboration with NE Department of Health and Human Services 
conducted on-site visits to assess infection prevention and control programs (IPCP) 
in 15 OHDC between June 2016 and March 2018. The CDC Infection Prevention and 
Control Assessment Tool for Hemodialysis Facilities was used for IPCP evaluation. 
A  total of 124 questions, 76 of which represented best practice recommendations 
(BPR) were analyzed in 10 IC domains. Gap frequencies were calculated for each BPR. 
Fisher’s exact test was used to study the association of the identified gaps with typical 
patient census of the facilities and chain affiliation (CA).
Results. Of the 15 OHDC, seven were large centers (typically following >50 
patients) and 11 were part of national chains. Important IC gaps exist in all OHDC. 
A median of 64 (range 57–70) of 76 BPR were being followed by OHDC or were nonap-
plicable to them. The IC Program and Infrastructure domain had the highest frequency 
of IC gaps (Figure 1). Figure 2 describes the top 5 IC gaps. Smaller OHDC (sODHC) 
and those without CA performed better in a few areas. For example, a higher proportion 
of sODHC had work exclusion policies that encourage reporting of illness without any 
penalty when compared with larger OHDC (75% vs. 0, P = 0.01). Similarly, a higher pro-
portion of sOHDC provided space and encouraged persons with symptoms of respira-
tory infection to sit as far away from others as possible in nonclinical areas (63% vs. 0, 
P < 0.05). None of the nonchain OHDC had shared computer charting terminals when 
compared with 64% of OHDC with CA (P = 0.08) and a majority of nonchain OHDC 
provided space and encouraged persons to maintain distance with others when having 
respiratory symptoms as opposed to a minority of OHDC with CA (75% vs. 18%, 0.08).
Conclusion. Important IC gaps exist in OHDC and require mitigation. Informing 
OHDC of existing IC gaps may help in BPR implementation. Larger scale studies 
should focus on identifying factors promoting certain BPR implementation in smaller 
and nonchain OHDC.
Disclosures. All authors: No reported disclosures.
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Background. Antibiotics are frequently prescribed inappropriately in nursing 
homes (NHs); however, national estimates of NH antibiotic use are limited. We aimed 
to describe antibiotic prescribing in US NHs to identify potential targets for antibiotic 
stewardship.
Methods. A  descriptive analysis was conducted using the 2014 proprietary 
IQVIA long-term care (LTC) Xponent database, which captures oral and intrave-
nous antibiotic prescription transactions from sampled LTC pharmacies representing 
70–85% of the LTC market. The data are projected to 100% of the US LTC market. 
Denominators for rate calculations were captured from the 2014 Minimum Data Set 
as the number of residents with at least one resident day in an NH in 2014. Antibiotic 
transaction counts and rates were calculated by resident gender, age, US census region, 
route of administration, antibiotic class and agent, and total transaction counts were 
summarized by provider type. Prescribing patterns for antibiotic classes and agents 
stratified by resident age were also calculated.
Results. In 2014, there were over 14 million antibiotic transactions in LTC phar-
macies, for a rate of 3,302 per 1,000 residents. Female residents accounted for 62% 
of antibiotic transactions at a rate of 3,305 transactions per 1,000 residents compared 
with 3,240 per 1,000 male residents. Antibiotic prescribing was highest in the South 
at 3,752 transactions per 1,000 residents (vs. 2,601 per 1,000 residents in the West). 
Oral antibiotics accounted for 85% of transactions. Fluoroquinolones were the most 
frequently prescribed antibiotic class (22%; 723 transactions per 1,000 residents) and 
the most common agents were levofloxacin, ciprofloxacin, and sulfamethoxazole–tri-
methoprim. Stratified by age, the percent change in prescribing rates among residents 
aged <85 to residents aged ≥85 was largest for fluoroquinolones (645 vs. 883)  and 
urinary anti-infectives (210 vs. 319). Internal medicine and family practice providers 
accounted for 37% and 32% of all antibiotic transactions, respectively.
Conclusion. A potential antibiotic stewardship target in NHs is fluoroquinolone 
prescribing. Targeting states in the South for interventions may have the largest impact.
Figure. Antibiotic prescribing rates in long-term care by U.S. census regions
Disclosures. All authors: No reported disclosures.
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Background. Residents of pediatric chronic care facilities (PCCFs) are vulnerable 
to acute respiratory infections (ARIs) due to their underlying medical conditions and 
infection control challenges in congregate living.
Methods. We conducted active, prospective surveillance for ARIs (defined as ≥2 
new signs/symptoms of respiratory illness) among all residents in three PCCFs near 
New York City from December 7, 2016 to May 7, 2017. The parents/guardians of some 
residents also provided consent for research specimen collection at the start of the 
study. In that subset, nasopharyngeal swabs were obtained ≤4 days of ARI symptom 
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